Role of p53 in growth suppression by bromodeoxyuridine in human gastric cancer cell lines

Guang Zhi Zuan, Hiroyuki Sugihara, Dunfa Peng, Zhi Qiang Ling, Xiao Hong Yao, Kazusada Yoshitake, Takanori Hattori

Research output: Contribution to journalArticle

Abstract

Bromodeoxyuridine (BrdU) is known to cause base mispairs and DNA strand breaks during DNA synthesis, culminating in growth suppression. To know whether P53 gene plays any role in the BrdU-induced growth suppression, we continuously gave BrdU (20 μM) to the synchronized culture of human gastric cancer cell lines, MKN-45 (P53-wild type) and MKN-28 (P53-mutant), shortly after release from the G1/S block by hydroxyurea. In comparison with the control culture, the growth of MKN-28 was not suppressed until 48 hr of BrdU exposure, while that of MKN-45 was already suppressed at the 24 hr point. Continuous exposure to BrdU caused a S-phase delay and G2 arrest of around 6 hr each in MKN-45 and a delay only of the second S phase in MKN-28 in comparison with synchronized control cultures of matched cell cycle phase. BrdU-exposed MKN-45 cells showed a significantly higher incidence of apoptosis after the cells passed through the first G2 phase and the second S/G2 phases, but MKN-28 did not. It thus appears that the delays of S/G2 phases and an increased incidence of apoptosis in the first cell cycle are p53-dependent. The growth suppression in the second S/G2 phase or later observed in both of the cell lines may be p53-independent.

Original languageEnglish (US)
Pages (from-to)429-437
Number of pages9
JournalActa Histochemica et Cytochemica
Volume33
Issue number6
DOIs
StatePublished - Dec 1 2000
Externally publishedYes

Fingerprint

Bromodeoxyuridine
Stomach Neoplasms
S Phase
G2 Phase
Cells
Cell Line
Growth
Cell culture
Cell Cycle
Apoptosis
DNA Breaks
Hydroxyurea
DNA
Incidence
p53 Genes
Genes

Keywords

  • Apoptosis
  • Bromodeoxyuridine
  • Cell cycle
  • Gastric cancer cell line
  • p53

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Biochemistry
  • Physiology
  • Histology
  • Cell Biology

Cite this

Role of p53 in growth suppression by bromodeoxyuridine in human gastric cancer cell lines. / Zuan, Guang Zhi; Sugihara, Hiroyuki; Peng, Dunfa; Ling, Zhi Qiang; Yao, Xiao Hong; Yoshitake, Kazusada; Hattori, Takanori.

In: Acta Histochemica et Cytochemica, Vol. 33, No. 6, 01.12.2000, p. 429-437.

Research output: Contribution to journalArticle

Zuan, Guang Zhi ; Sugihara, Hiroyuki ; Peng, Dunfa ; Ling, Zhi Qiang ; Yao, Xiao Hong ; Yoshitake, Kazusada ; Hattori, Takanori. / Role of p53 in growth suppression by bromodeoxyuridine in human gastric cancer cell lines. In: Acta Histochemica et Cytochemica. 2000 ; Vol. 33, No. 6. pp. 429-437.
@article{9956e852123a4043a4072e6bb96b6e85,
title = "Role of p53 in growth suppression by bromodeoxyuridine in human gastric cancer cell lines",
abstract = "Bromodeoxyuridine (BrdU) is known to cause base mispairs and DNA strand breaks during DNA synthesis, culminating in growth suppression. To know whether P53 gene plays any role in the BrdU-induced growth suppression, we continuously gave BrdU (20 μM) to the synchronized culture of human gastric cancer cell lines, MKN-45 (P53-wild type) and MKN-28 (P53-mutant), shortly after release from the G1/S block by hydroxyurea. In comparison with the control culture, the growth of MKN-28 was not suppressed until 48 hr of BrdU exposure, while that of MKN-45 was already suppressed at the 24 hr point. Continuous exposure to BrdU caused a S-phase delay and G2 arrest of around 6 hr each in MKN-45 and a delay only of the second S phase in MKN-28 in comparison with synchronized control cultures of matched cell cycle phase. BrdU-exposed MKN-45 cells showed a significantly higher incidence of apoptosis after the cells passed through the first G2 phase and the second S/G2 phases, but MKN-28 did not. It thus appears that the delays of S/G2 phases and an increased incidence of apoptosis in the first cell cycle are p53-dependent. The growth suppression in the second S/G2 phase or later observed in both of the cell lines may be p53-independent.",
keywords = "Apoptosis, Bromodeoxyuridine, Cell cycle, Gastric cancer cell line, p53",
author = "Zuan, {Guang Zhi} and Hiroyuki Sugihara and Dunfa Peng and Ling, {Zhi Qiang} and Yao, {Xiao Hong} and Kazusada Yoshitake and Takanori Hattori",
year = "2000",
month = "12",
day = "1",
doi = "10.1267/ahc.33.429",
language = "English (US)",
volume = "33",
pages = "429--437",
journal = "Acta Histochemica et Cytochemica",
issn = "0044-5991",
publisher = "Japan Society of Histochemistry and Cytochemistry",
number = "6",

}

TY - JOUR

T1 - Role of p53 in growth suppression by bromodeoxyuridine in human gastric cancer cell lines

AU - Zuan, Guang Zhi

AU - Sugihara, Hiroyuki

AU - Peng, Dunfa

AU - Ling, Zhi Qiang

AU - Yao, Xiao Hong

AU - Yoshitake, Kazusada

AU - Hattori, Takanori

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Bromodeoxyuridine (BrdU) is known to cause base mispairs and DNA strand breaks during DNA synthesis, culminating in growth suppression. To know whether P53 gene plays any role in the BrdU-induced growth suppression, we continuously gave BrdU (20 μM) to the synchronized culture of human gastric cancer cell lines, MKN-45 (P53-wild type) and MKN-28 (P53-mutant), shortly after release from the G1/S block by hydroxyurea. In comparison with the control culture, the growth of MKN-28 was not suppressed until 48 hr of BrdU exposure, while that of MKN-45 was already suppressed at the 24 hr point. Continuous exposure to BrdU caused a S-phase delay and G2 arrest of around 6 hr each in MKN-45 and a delay only of the second S phase in MKN-28 in comparison with synchronized control cultures of matched cell cycle phase. BrdU-exposed MKN-45 cells showed a significantly higher incidence of apoptosis after the cells passed through the first G2 phase and the second S/G2 phases, but MKN-28 did not. It thus appears that the delays of S/G2 phases and an increased incidence of apoptosis in the first cell cycle are p53-dependent. The growth suppression in the second S/G2 phase or later observed in both of the cell lines may be p53-independent.

AB - Bromodeoxyuridine (BrdU) is known to cause base mispairs and DNA strand breaks during DNA synthesis, culminating in growth suppression. To know whether P53 gene plays any role in the BrdU-induced growth suppression, we continuously gave BrdU (20 μM) to the synchronized culture of human gastric cancer cell lines, MKN-45 (P53-wild type) and MKN-28 (P53-mutant), shortly after release from the G1/S block by hydroxyurea. In comparison with the control culture, the growth of MKN-28 was not suppressed until 48 hr of BrdU exposure, while that of MKN-45 was already suppressed at the 24 hr point. Continuous exposure to BrdU caused a S-phase delay and G2 arrest of around 6 hr each in MKN-45 and a delay only of the second S phase in MKN-28 in comparison with synchronized control cultures of matched cell cycle phase. BrdU-exposed MKN-45 cells showed a significantly higher incidence of apoptosis after the cells passed through the first G2 phase and the second S/G2 phases, but MKN-28 did not. It thus appears that the delays of S/G2 phases and an increased incidence of apoptosis in the first cell cycle are p53-dependent. The growth suppression in the second S/G2 phase or later observed in both of the cell lines may be p53-independent.

KW - Apoptosis

KW - Bromodeoxyuridine

KW - Cell cycle

KW - Gastric cancer cell line

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0034451055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034451055&partnerID=8YFLogxK

U2 - 10.1267/ahc.33.429

DO - 10.1267/ahc.33.429

M3 - Article

AN - SCOPUS:0034451055

VL - 33

SP - 429

EP - 437

JO - Acta Histochemica et Cytochemica

JF - Acta Histochemica et Cytochemica

SN - 0044-5991

IS - 6

ER -